本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEWAMSTERDAM PHARMA CO NV

31.35
+0.08000.26%
盘后31.350.00000.00%16:10 EDT
成交量:60.54万
成交额:1,874.57万
市值:36.04亿
市盈率:-18.22
高:31.58
开:30.71
低:29.99
收:31.27
52周最高:42.00
52周最低:14.06
股本:1.15亿
流通股本:6,472.04万
量比:0.60
换手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-1.7211
每股收益(LYR):-1.7211
净资产收益率:-28.29%
总资产收益率:-17.27%
市净率:5.27
市盈率(LYR):-18.22

数据加载中...

2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities